Marriage Counselors in Tualatin, OR Accepting Medicare

6 Marriage Counselors found. Showing 1 - 6

Marla Christensen, LPC Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 18650 Sw Boones Ferry Rd Ste 3, Tualatin, OR 97062 Phone: 503-850-4455

Michelle Engblom-deglmann, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 19824 Sw 72nd Ave Ste 102, Tualatin, OR 97062 Phone: 503-610-3676

Meghan Lundeen Pence, MA Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 19824 Sw 72nd Ave Ste 102, Tualatin, OR 97062 Phone: 503-908-9084

Took Smoot Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 19365 Sw 65th Ave Ste 105, Tualatin, OR 97062 Phone: --

Mr. Travis Waits, MA, LMFT, LPC Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 18650 Sw Boones Ferry Rd, Suite 3, Tualatin, OR 97062 Phone: 503-680-4734    Fax: 503-536-6839

Dr. Kimberley D Dockery, PH.D., LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 19250 Sw 65th Ave Ste 300, Tualatin, OR 97062 Phone: 503-692-1242    Fax: 503-691-3615

News Archive

5-LO enzyme plays important role in the survival of leukaemic AML stem cells

Despite improved therapy, only one out of every two adult patients survive acute myeloid leukaemia (AML). The mean survival time for this disease, which predominantly occurs in the elderly, is less than a year for patients over 65 years. It is assumed that leukaemic stem cells, which cannot be completely eliminated during treatment, are the origin of relapse.

Novel imaging agents and techniques can revolutionize medical imaging science: JNM

A study published in the July issue of The Journal of Nuclear Medicine (JNM) reports on investigative research of a novel optical imaging technique called "Cerenkov luminescence imaging (CLI)." According to the authors, the technique could lead to the faster and more cost-effective development of radiopharmaceuticals for the diagnosis and treatment of cancer and other conditions.

PIMs usage among elderly patients may increase adverse events and health care costs

A new study provides important evidence that the use of certain potentially inappropriate medications (PIMs) among the elderly may increase adverse events and health care costs.

OK from the FDA for synthetic marijuana drug

Despite saying quite recently that it does not support the use of marijuana for medical purposes, the U.S. Food and Drug Administration (FDA) has given marketing approval for a drug which is a synthetic version of the active ingredient in marijuana.

Clinical trials of daily oral antiretroviral dosing as pre-exposure prophylaxis

Writing in the journal Science, an international team of researchers, clinicians and others explains that a promising, relatively new approach is for people not infected but at high risk to take drugs that might prevent them from contracting HIV. But debate over the particulars of the strategy has slowed progress.

Read more Medical News

› Verified 9 days ago